Royal Bank of Canada’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,400
Closed -$136K 7380
2023
Q4
$136K Buy
+19,400
New +$129K ﹤0.01% 5407
2023
Q3
Sell
-123,200
Closed -$683K 7385
2023
Q2
$683K Buy
+123,200
New +$676K ﹤0.01% 3700
2022
Q4
Sell
-90,000
Closed -$802K 7539
2022
Q3
$802K Hold
90,000
﹤0.01% 3635
2022
Q2
$932K Buy
+90,000
New +$1.34M ﹤0.01% 3572

Other funds holding MSOS

Royal Bank of Canada's MSOS Position: Q1 2026 in Review

Royal Bank of Canada reduced its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 29% in Q1 2026, selling an estimated $11.7K and leaving 6,962 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #5805.

Royal Bank of Canada first reported a position in MSOS in Q4 2020 and has held it in 22 quarters since. The position peaked at $2M in Q2 2023. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Royal Bank of Canada held 6,962 shares of AdvisorShares Pure US Cannabis ETF worth $25K as of Q1 2026.
  • Royal Bank of Canada sold 2,858 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $11.7K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5805 holding.
  • Royal Bank of Canada first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's AdvisorShares Pure US Cannabis ETF position peaked at $2M in Q2 2023.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.